Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

A-228839: synthesis of a new agent for blocking Ras function

March 31, 2000

Cell Therapeutics submits NDA for arsenic trioxide

March 31, 2000

Breast cancer trial of annamycin commenced by Aronex

March 31, 2000

UroGen awarded SBIR grant to support prostate cancer gene therapy product development

March 31, 2000

Phase I/II clinical trial data reported for MTC-DOX in liver cancer

March 31, 2000

Clinical trial of STR in Ewing's sarcoma initiated by NeoRx

March 30, 2000

New farnesyltransferase inhibitor L-779575 presented by Merck this week

March 29, 2000

ACS news: BMS presents potent new inhibitor of cyclin-dependent kinases

March 29, 2000

Kinetek validates ILK inhibition as potential cancer therapy

March 29, 2000

NCI initiates third phase II trial of O6-benzylguanine in combination with BCNU

March 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...